Skip to main content

Published locations for Despite risks and warnings, CNS polypharmacy is prevalent among patients with dementia

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Despite risks and warnings, CNS polypharmacy is prevalent among patients with dementia

User login

  • Reset your password
  • /content/despite-risks-and-warnings-cns-polypharmacy-prevalent-among-patients-dementia
  • /familypracticenews/article/237289/alzheimers-cognition/despite-risks-and-warnings-cns-polypharmacy
  • /internalmedicinenews/article/237289/alzheimers-cognition/despite-risks-and-warnings-cns-polypharmacy
  • /neurologyreviews/article/237289/alzheimers-cognition/despite-risks-and-warnings-cns-polypharmacy
  • /jcomjournal/article/237289/alzheimers-cognition/despite-risks-and-warnings-cns-polypharmacy
  • /psychiatry/article/237289/alzheimers-cognition/despite-risks-and-warnings-cns-polypharmacy-prevalent
  • /internalmedicine/article/237289/alzheimers-cognition/despite-risks-and-warnings-cns-polypharmacy
  • /neurology/article/237289/alzheimers-cognition/despite-risks-and-warnings-cns-polypharmacy-prevalent
  • /familymedicine/article/237289/alzheimers-cognition/despite-risks-and-warnings-cns-polypharmacy
  • /breast-cancer-icymi/article/237289/alzheimers-cognition/despite-risks-and-warnings-cns-polypharmacy
  • /b-cell-lymphoma-icymi/article/237289/alzheimers-cognition/despite-risks-and-warnings-cns
  • /clinicalpsychiatrynews/article/237289/alzheimers-cognition/despite-risks-and-warnings-cns